A randomized phase II study of Cisplatin plus S-1 versus Cisplatin plus Pemetrexed, with thoracic radiotherapy for locally advanced non-squamous non-small cell lung cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms SPECTRA
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress
- 07 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 31 Jul 2015 Planned number of patients changed from 70 to 100 as reported by University Hospital Medical Information Network - Japan.